Back to search

Article

Analysis of the transcriptome for novel therapeutic targets, and investigation of the role of APOBEC3B in chronic myeloid leukaemia stem cells

2018-01-01

Abstract excerpt

The introduction to the clinic of tyrosine kinase inhibitors (TKIs) for the treatment of chronic myeloid leukaemia (CML) revolutionized the outlook for patients. These drugs manage disease highly effectively in the majority of patients, through elimination of the bulk of the leukaemic cells from the blood and bone marrow. However, they fail to eradicate the underlying leukaemic stem cells (LSCs). Therefore, patien...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
43cf8467-c679-5493-af49-4164e245a401
DOI
10.5525/gla.thesis.75031
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Analysis of the transcriptome for novel therapeutic targets, and investigation of the role of APOBEC3B in chronic myeloid leukaemia stem cellsDOI 10.5525/gla.thesis.75031
Select a neighboring publication to make it the new centre.